Can Plaque Really Shrink? Inside the FLOWPROMOTE Trial Results
From Dr Alo Show · · 9 min
This plays from the publisher's own server. We do not host a copy.
Description
Dr.
Alo and Hannah unpack FLOWPROMOTE, a new JAMA Cardiology trial that used full coronary CT scans to track plaque changes in statin naive patients over eighteen months. They explain why soft plaque shrank in 98 percent of patients on rosuvastatin plus ezetimibe, and why a rising calcium score during treatment is actually a good sign, not a warning. Listeners walk away with a clear picture of what the LDL and plaque numbers really mean for their own heart health.
Read the full post: https://www.dralo.net/blog/reverse-soft-plaque
Questions this episode answers: Can coronary plaque actually shrink or reverse? Does a rising calcium score mean my statin isn't working? What is the difference between soft plaque and calcified plaque? Is rosuvastatin plus ezetimibe better than atorvastatin alone? What LDL level helps shrink plaque? What is the FLOWPROMOTE trial?
Keywords: plaque reversal, flowpromote trial, rosuvastatin ezetimibe, coronary ct angiogram, soft plaque, calcified plaque, ldl cholesterol, calcium score, statin naive patients, heart disease prevention, apob testing, coronary artery disease
This episode is for education only and is not medical advice. Talk to your own clinician about your own situation.
#heart #cardiology #drAlo #flowpromote #plaquereversal #statins #heartscan